OptiNose, Inc. is a specialty pharmaceutical company that develops and commercializes products for patients treated by ear, nose, and throat (ENT) and allergy specialists. The company's products are designed to improve the efficacy, safety, and convenience of existing treatments, as well as to address unmet needs in the treatment of ENT and allergy conditions. OptiNose's products include XHANCE, a prescription nasal spray for the treatment of nasal polyps in adults, and ONZETRA Xsail, a prescription nasal powder for the treatment of migraines. The company was founded in 2010 and is headquartered in Yardley, Pennsylvania.